Literature DB >> 8954072

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study.

S Soule, G Conway, A Hatfield, H Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8954072     DOI： 10.1210/jcem.81.12.8954072

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Lanreotide autogel is a therapeutic option for patients who develop acute pancreatitis after somatostatin analog treatment.

Authors:  E Boix; P López; M Pérez-Mateo; A Picó
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 2.  Contemporary review of drug-induced pancreatitis: A different perspective.

Authors:  Whitney Y Hung; Odaliz Abreu Lanfranco
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 3.  Treatment of pituitary tumors: somatostatin.

Authors:  Maria A Tichomirowa; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.